cilastatin has been researched along with Neutropenia in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (26.19) | 18.7374 |
1990's | 23 (54.76) | 18.2507 |
2000's | 7 (16.67) | 29.6817 |
2010's | 1 (2.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batlle, M; de la Cámara, R; de la Rubia, J; Debén, G; Díaz, J; García, R; Jarque, I; Juliá, A; Lahuerta, JJ; López, J; Martino, R; Montesinos, P; Rovira, M; Sanz, MA; Vázquez, L | 1 |
Arnold, HM; Augustin, KM; Casabar, E; Dubberke, ER; Hladnik, LM; McKinnon, PS; Reichley, RM; Ritchie, DJ; Westervelt, P | 1 |
Erdem, E; Gulec, SG; Kebudi, R; Vural, S; Yildirmak, Y | 1 |
Björkholm, M; Cherif, H; Engervall, P; Hast, R; Johansson, P; Kalin, M; Ljungman, P | 1 |
Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C | 1 |
Anagnostopoulos, A; Fassas, A; Hadjikyrkou, M; Kontodimou, A; Papageorgiou, T; Proya, E | 1 |
Brown, KR; Calandra, GB; Ricci, FM; Wang, C | 1 |
Ishibashi, T; Okada, H; Omori, S; Sasada, M; Sawada, H; Suzuki, T; Tajima, M; Yamamoto, K; Yasuda, N; Yumoto, Y | 1 |
Allen, DM; Ang, PT; Au, E; Tow, A | 1 |
Eguchi, K; Kojima, A; Ohe, Y; Okamoto, H; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Soejima, Y; Tamura, T | 1 |
Barros, KV; Bianchi, A; Kusano, E; Melaragno, R; Petrilli, AS; Ribeiro, RC; Silva, AA | 1 |
de Vega, T; Fariñas, MC; Garmendia, J; González-Macías, J | 1 |
Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M | 1 |
Deaney, NB; Tate, H | 1 |
Björkholm, M; Engervall, P; Günther, G; Hast, R; Kalin, M; Ljungman, P; Lönnqvist, B; Ringertz, S; Stiernstedt, G | 1 |
Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
Gaya, H | 1 |
Abi-Said, D; Bodey, GP; Karl, CL; Raad, II; Rolston, KV | 1 |
Biron, P; Cure, H; Fuhrmann, C; Grès, JJ; Lefebvre, D; Rollin, C; Soler-Michel, P; Thyss, A; Viens, P; Viot, M | 1 |
Başkan, S; Ozyilkan, O; Yalçintaş, U | 1 |
Anaissie, EJ; Gubbins, PO; McConnell, SA; Penzak, SR; Warmack, TS | 1 |
Arranz, R; de La Cámara, R; Font, P; Leyra, F; María Fernández Rañada, J; Pajuelo, F; Rivero, N | 1 |
Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
Itoh, M; Nakano, T; Sakurai, M | 1 |
Bosseray, A; Brion, JP; Hollard, D; Michallet, M; Micoud, M; Nicolini, F; Stahl, JP | 1 |
Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT | 1 |
Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M | 1 |
Shevchuk, YM | 1 |
Huijgens, PC; Langenhuijsen, MM; Ossenkoppele, GJ; Simoons-Smit, AM; van Loenen, AC; van Pampus, EC; Weijers, TF; Wijermans, PW | 1 |
Chan, TK; Chau, PY; Chiu, E; Lam, WK; Liang, R; Todd, D; Yung, R | 1 |
Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C | 1 |
Farrell, I; Janmohamed, RM; Kelly, J; Leyland, MJ | 1 |
Inoue, M; Kawa, K; Konishi, S; Naya, Y; Nishida, M; Sako, M; Yabuuchi, H | 1 |
Bucaneve, G; Del Favero, A; Menichetti, F; Minotti, V; Pasticci, MB; Tonato, M | 1 |
Agaliotis, D; Ezzeddine, H; Gala, JL; Gigi, J; Michaux, JL; Vandercam, B; Wauters, G | 1 |
Hashizume, T; Kemi, M; Komatsu, T; Ogashiwa, M; Okumoto, Y; Takase, Z | 1 |
Fridrik, MA; Grafinger-Witt, E; Leisch, F; Wahl, G | 1 |
Chan, TK; Chau, PY; Lam, WK; Liang, R; So, SY; Todd, D; Yung, R | 1 |
Andrien, F; Anniko, M; Baudrihaye, M; Bow, E; Burman, LA; Louie, T; Norberg, B; Norrby, SR; Runde, V; Vandercam, B | 1 |
Black, D; Kirby, WM; Kwok, K; Miller, S; Mortimer, J | 1 |
Andremont, A; Baruchel, A; Hartmann, O; Tancrède, C | 1 |
Alvarez, ME; Bodey, GP; Fainstein, V; Jones, PG; Rolston, KV; Steelhammer, L | 1 |
1 review(s) available for cilastatin and Neutropenia
Article | Year |
---|---|
A meta-analysis of clinical studies of imipenem-cilastatin for empirically treating febrile neutropenic patients.
Topics: Cilastatin; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Imipenem; Neutropenia; Protease Inhibitors; Thienamycins; Treatment Outcome | 1996 |
23 trial(s) available for cilastatin and Neutropenia
Article | Year |
---|---|
Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2010 |
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome | 2004 |
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome | 2005 |
Safety and tolerance comparison of imipenem-cilastatin to cephalothin and cefazolin.
Topics: Cefazolin; Cephalothin; Cilastatin; Cyclopropanes; Humans; Leukocyte Count; Liver Function Tests; Neutropenia | 1983 |
[Effect of a combination treatment using imipenem/cilastatin sodium with G-CSF on infections in neutropenic patients with hematological malignancies].
Topics: Adult; Aged; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Imipenem; Immunocompromised Host; Male; Middle Aged; Neutropenia | 1995 |
Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
Topics: Antineoplastic Agents; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Costs and Cost Analysis; Drug Combinations; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Neutropenia; Sepsis | 1994 |
A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients.
Topics: Adult; Aged; Amikacin; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome | 1994 |
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins | 1995 |
Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Retreatment; Treatment Outcome | 1996 |
Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Child; Cilastatin; Drug Synergism; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Netilmicin; Neutropenia; Postoperative Complications; Protease Inhibitors; Thienamycins; Treatment Outcome | 1997 |
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
Topics: Antineoplastic Agents; Cefepime; Cephalosporins; Cilastatin; Drug Therapy, Combination; Fever; Humans; Imipenem; Neoplasms; Neutropenia; Risk Factors; Survival Analysis | 1998 |
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam | 1999 |
[Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)].
Topics: Adolescent; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2001 |
[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Vancomycin | 1992 |
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome | 1991 |
Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies.
Topics: Antibiotics, Antineoplastic; Cilastatin; Drug Resistance, Microbial; Fever; Hematologic Diseases; Humans; Imipenem; Neutropenia; Time Factors | 1991 |
Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Ceftriaxone versus imipenem/cilastatin as empirical monotherapy for infections in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Random Allocation; Remission Induction | 1989 |
Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Female; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation | 1989 |
Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillin Resistance; Piperacillin; Prospective Studies; Random Allocation; Thienamycins | 1987 |
Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Mezlocillin; Neoplasms; Neutropenia; Thienamycins | 1988 |
Imipenem-cilastatin as initial therapy for febrile cancer patients.
Topics: Adult; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia; Sepsis; Thienamycins | 1986 |
18 other study(ies) available for cilastatin and Neutropenia
Article | Year |
---|---|
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin | 2009 |
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Fever; Hospital Mortality; Humans; Imipenem; Male; Meropenem; Middle Aged; Neutropenia; Retreatment; Seizures; Thienamycins; Time Factors | 2009 |
Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Treatment Outcome | 1989 |
Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Neoplasms; Neutropenia | 1993 |
Severe neutropenia in a patient treated with imipenem/cilastatin.
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Neutropenia; Osteomyelitis | 1993 |
Carbapenems in febrile neutropenic patients.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Fever; Humans; Imipenem; Neutropenia | 1997 |
How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?
Topics: Adolescent; Adult; Aged; Cilastatin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Protease Inhibitors; Retrospective Studies; Thienamycins; Treatment Outcome | 1998 |
Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy.
Topics: Adult; Aged; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Reactions; Drug Combinations; Drug Hypersensitivity; Fever; Humans; Imipenem; Incidence; Middle Aged; Neutropenia; Penicillins; Retrospective Studies | 2000 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
[Clinical evaluation of imipenem/cilastatin sodium against infections in compromised children (malignancy, hematological disease, collagen disease)].
Topics: Adolescent; Age Factors; Bacterial Infections; Child; Child, Preschool; Cilastatin; Collagen Diseases; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Immunocompromised Host; Infant; Male; Neoplasms; Neutropenia; Opportunistic Infections | 1992 |
Antimicrobial agents in neutropenic patients with unexplained fever.
Topics: Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Fever of Unknown Origin; Humans; Imipenem; Infections; Neutropenia | 1991 |
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1990 |
Pharmacokinetics of imipenem/cilastatin in neutropenic patients with haematological malignancies.
Topics: Acute Disease; Adult; Agranulocytosis; Blood Preservation; Chromatography, High Pressure Liquid; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Half-Life; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Middle Aged; Neutropenia | 1990 |
[Clinical study of imipenem/cilastatin sodium in children with severe infections].
Topics: Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Female; Hematologic Diseases; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia | 1990 |
Therapeutic effects of imipenem-cilastatin on experimental intrauterine infections in rats.
Topics: Ampicillin; Animals; Cefazolin; Cilastatin; Cyclopropanes; Drug Combinations; Drug Evaluation, Preclinical; Endometritis; Enterococcus faecalis; Escherichia coli Infections; Female; Imipenem; Microbial Sensitivity Tests; Neutropenia; Rats; Rats, Inbred Strains; Streptococcal Infections; Thienamycins | 1987 |
[Imipenem/cilastatin as monotherapy in neutropenic patients with fever].
Topics: Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever of Unknown Origin; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies | 1988 |
Imipenem/cilastatin as initial therapy for febrile neutropenic patients.
Topics: Agranulocytosis; Cilastatin; Dipeptidases; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Imipenem; Male; Microbial Sensitivity Tests; Neutropenia | 1988 |
Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
Topics: Adolescent; Adult; Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Dipeptidases; Drug Therapy, Combination; Enterobacteriaceae; Female; Gram-Negative Bacteria; Humans; Imipenem; Intestines; Male; Neoplasms; Neutropenia; Thienamycins | 1986 |